J&J Pharma: Porter's Five Forces – Customers & Substitutes
This paper analyzes two components of Porter's Five Forces framework as applied to Johnson & Johnson's pharmaceutical division: the bargaining power of customers and the threat of substitute products. It examines how individual consumers and healthcare providers exert influence through switching costs, information availability, and prescribing authority. The paper also explores substitute threats from generic drugs, alternative therapies such as acupuncture and herbal remedies, and competing pharmaceutical products. Drawing on academic and industry sources, it argues that J&J must continuously innovate and price strategically to maintain its competitive position in an increasingly informed and skeptical marketplace.
- Introduction to Customer Power in Pharma: Defines customer power in pharmaceutical markets
- Sources of Customer Bargaining Power: Switching costs, information access, and provider influence
- Threat of Substitute Products: Overview of substitute product threat sources
- Types of Substitute Threats Facing J&J: Generics, alternative therapies, and competitor drugs
- Conclusion: Innovation as J&J's competitive response strategy
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Applies a well-known strategic framework (Porter's Five Forces) concretely to a real company, grounding abstract concepts in industry-specific examples.
- Supports each analytical claim with cited academic or industry sources, lending credibility to the argument.
- Uses specific illustrative examples — such as acupuncture for chronic pain and herbal remedies for anxiety — to make abstract competitive threats tangible and relatable.
Key academic technique demonstrated
The paper demonstrates applied framework analysis: it takes a canonical business strategy model and systematically maps each sub-factor to real-world evidence from the pharmaceutical sector. Rather than simply defining Porter's concepts, the author shows how each force manifests specifically for Johnson & Johnson, which is the hallmark of strong applied business analysis.
Structure breakdown
The paper is organized into two major analytical sections — customer power and substitute product threats — each introduced with a clear conceptual definition followed by sub-factors and supporting evidence. Citations are integrated within each sub-section rather than clustered at the end of arguments, maintaining a steady evidence base throughout. The structure mirrors the logical scaffolding of Porter's model itself, making the analysis easy to follow.
Introduction to Customer Power in Pharma
The power of customers refers to the degree of influence that customers have over a company and its products. In the pharmaceutical industry, customers include both individual consumers and healthcare providers, such as hospitals and clinics. Customers in the pharmaceutical industry have significant power for several reasons.
Sources of Customer Bargaining Power
In the pharmaceutical industry, customers often must use a specific drug to treat a certain condition, and switching to another drug may not be an option. This is especially true for patients who depend on specific drugs to manage chronic conditions. As a result, customers are less likely to switch to a competitor's product, giving pharmaceutical companies significant pricing leverage over them (Janssen, 2019).
Due to the availability of information online and through healthcare providers, customers are becoming more knowledgeable about their healthcare needs and options (Eysenbach, 2000). This increased knowledge makes them more informed when making decisions about their treatment, which can lead to increased bargaining power as patients arrive at appointments with greater awareness of available alternatives.
Healthcare providers also have significant bargaining power due to their ability to influence the prescribing decisions of patients. Doctors and other healthcare providers can choose to prescribe — or not prescribe — a certain drug, which can greatly affect the sales and success of a pharmaceutical company.
Threat of Substitute Products
The threat of substitute products refers to the likelihood of customers switching to a competitor's product or a substitute that serves the same purpose. In the pharmaceutical industry, this threat can come from a variety of sources, including generic drugs, alternative therapies, and competing branded products.
Conclusion
Both customer bargaining power and the threat of substitutes present ongoing strategic challenges for Johnson & Johnson's pharmaceutical division. Whether driven by patent expirations, growing patient knowledge, or cultural shifts toward alternative medicine, these competitive forces require J&J to invest continuously in innovation, pricing strategy, and stakeholder relationships to maintain its market position.
Cho, H. E., Billig, J. I., Byrnes, M. E., Haase, S. C., Waljee, J. F., & Chung, K. C. (2022). Trust and distrust in opioid decision-making: a qualitative assessment of patient-doctor relationship. The Journal of Hand Surgery, 47(2), 151–159.
Eysenbach, G. (2000). Consumer health informatics. BMJ, 320(7251), 1713–1716.
Janssen, A. (2019). Switching costs, quality misconceptions and behavioral pricing in the pharmaceutical market. In Essays on pharmaceutical markets and parliamentary speeches (PhD thesis). Stockholm School of Economics, Stockholm, Sweden.
Always verify citation format against your institution’s current style guide requirements.